The increasing cases of COVID-19 have caused significant disruptions around the world, as well as an impact on the patient population's demand for urinary catheters. Urinary catheters were being used for surgical applications, and demand was influenced to some extent by the temporary postponement of various elective surgeries as authorities sought to ensure the availability of resources for COVID-19 patients. However, a few launches have contributed to the segment's steady growth due to the increasing infection rate.
According to Data Bridge Market Research the Rectal Catheters Market accounted for USD 601.67 million in 2021, and expected to reach USD 1134.00 million by 2029. The market is expected to grow with a CAGR of 6.8% in the forecast period of 2022 to 2029.
“Rising Chronic Cases to Facilitate Market Growth”
The market is expected to grow rapidly due to the rising prevalence of cardiovascular, neurologic, and urological disorders, as well as the increased use of minimally invasive procedures and the rising demand for antimicrobial catheters. Chronic diseases are becoming the leading cause of death and morbidity worldwide. According to the Brain Aneurysm Foundation in March 2021, brain aneurysms cause approximately 500,000 deaths worldwide each year, with half of these people being under the age of 50. In the United States, the annual rate of rupture is around 8-10 people per 100,000, or about 30,000 people. Thus, as the prevalence of neurovascular disorders rises, so the demand for neurovascular catheter devices also rises.
What restraints the growth of Rectal Catheters Market?
“High cost of rectal catheters”
The high cost of rectal catheters and complications such as bowel perforations, mucosal irritation, and others hamper the market growth. In addition, decreased awareness, social distress, and patient emotions will pose challenges to the rectal catheter market. However, a shortage of skilled professionals and the impact of COVID-19 on the supply chain will restrain and impede the growth rate of the rectal catheters market during the forecast period of 2022-2029.
“High Risk of Infections Through Catheters”
Catheters are either temporarily or permanently inserted into various parts of the body. However, any foreign object injected into the body poses the risk of infection. Urinary catheters, according to the United Kingdom Health Service, allow bacteria to enter the body. This can lead to infection in the urethra, bladder or in rare cases, the kidneys. Urinary tract infections are the name given to these types of infections (UTIs). As a result, the risk of infection may discourage patients from using catheters, slowing market growth.
Segmentation: Rectal Catheters Market
直腸導管市場根據產品類型、應用、用途和最終用途進行細分。
- 根據產品類型，直腸導管市場分為簡單直腸導管和複合直腸導管。
- 應用部分分為慢性胃腸病管理、大便失禁、腹瀉、便秘、藥物及液體輸送、手術等。
- 直腸導管市場的用途分為一次性和可重複使用。
- 直腸導管市場也根據最終用途細分為醫院、門診手術中心、診所和家庭護理機構。
區域洞察：亞太地區預計將主導直腸導管市場
由於北美地區醫療成本不斷上漲且醫療設施品質較高，預計該地區將佔據市場主導地位。
- 此外，由於亞太地區患者數量不斷增長且治療成本效益較高，該地區很可能在 2022 年至 2029 年的預測期內實現最高增長率。此外，這些公司還在新市場推出產品以增加消費者基礎和收入。此外，該市場也以合作、合併、收購、合資等競爭策略而聞名。
要了解有關該研究的更多信息，請訪問： https://www.databridgemarketresearch.com/reports/global-rectal-catheters-market
直腸導管市場的最新發展
- 2021 年，美敦力公司在歐洲推出了 Prevail 藥物塗層球囊 (DCB) 導管，並獲得 CE（歐洲合格認證）標誌。 Prevail DCB 是市場上最新的冠狀動脈 DCB，用於經皮冠狀動脈介入治療 (PCI) 過程中治療冠狀動脈疾病 (CAD) 患者的狹窄或阻塞的冠狀動脈。這將導致此類導管在治療心血管疾病方面的使用增加，並且市場成長將受益於微創手術趨勢的上升。
- 2022 年，Cerus Endovascular 的 027 微導管獲得 FDA 批准，該導管有兩種長度可供選擇，擴大了其產品組合，其中已經包括獲得 FDA 批准的 021 微導管平台。同樣，2021 年 2 月，加拿大衛生部批准了 Bactguard 的 TempSensor 導管。
直腸導管市場的主要參與者包括：
- 康樂保公司（美國）
- B.Braun SE（德國）
- BD（美國）
- Laborie（美國）
- Sterimed集團（印度）
- P3 Medical Ltd.（英國）
- Integra LifeSciences（美國）
- Gamma集團（義大利）
- Mediplus India Ltd.（印度）
- Ivor Shaw T/A Pennine Healthcare（英國）
- Amecath（埃及）
- gpcmedical（美國）
- Wellona Pharma（印度）
- Narang Medical Limited（美國）
- 安吉普拉斯特私人有限公司有限公司（印度）
- Runfold Plastics Ltd.（美國）
以上是報告中涉及的關鍵參與者，要了解更多有關直腸導管市場公司聯繫的詳盡列表， https://www.databridgemarketresearch.com/contact
研究方法：全球直腸導管市場
資料收集和基準年分析是使用具有大樣本量的資料收集模組完成的。使用市場統計和相干模型來分析和估計市場數據。此外，市場佔有率分析和關鍵趨勢分析是市場報告中的主要成功因素。 DBMR 研究團隊使用的關鍵研究方法是資料三角測量，其中涉及資料探勘、資料變數對市場的影響分析以及初步（產業專家）驗證。除此之外，資料模型還包括供應商定位網格、市場時間軸分析、市場概覽和指南、公司定位網格、公司市場份額分析、測量標準、全球與區域以及供應商份額分析。如有進一步疑問，請要求分析師致電。
